1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
OGE Energy reported second-quarter 2025 diluted earnings of $0.53 per share, up from $0.51 a year earlier, with net income of $107.5 million and operating revenues of $741.6 million. The company said its 2025 consolidated earnings are expected to land in the top half of its $2.21 to $2.33 per-share guidance range, which assumes normal weather for the rest of the year.
Q2 2025 diluted EPS was $0.53, versus $0.51 in Q2 2024; net income was $107.5 million, versus $102.3 million.
Operating revenues rose to $741.6 million from $662.6 million, while OG&E net income fell to $107.7 million from $109.3 million, which the filing attributes mainly to milder weather.
2025 consolidated EPS guidance remains $2.21 to $2.33, with earnings now expected in the top half of that range.
OGE Energy is constructing about 550 MW of natural gas combustion turbine generation, expected to be operational in 2026.
Norfolk Southern signed a merger agreement on July 28, 2025, under which Union Pacific will acquire it through a stock-and-cash transaction. Each Norfolk Southern share would convert into one Union Pacific share plus $88.82 in cash, and the deal requires Surface Transportation Board approval and shareholder votes at both companies.
Each Norfolk Southern share converts into one Union Pacific share plus $88.82 in cash
Either party may terminate if the mergers are not completed by January 28, 2028, subject to certain extensions
$2.5 billion termination fee payable by Union Pacific in certain regulatory-failure cases; a $2.5 billion fee applies to each party under specified circumstances
Three Norfolk Southern directors, including Mark George and Richard Anderson, would join Union Pacific's board
Ashland reported preliminary third-quarter fiscal 2025 sales of $463 million, down 15 percent from $544 million a year earlier, and a net loss of $742 million, or $(16.21) per diluted share, mainly due to a non-cash goodwill impairment charge of $706 million. The company also narrowed its full-year fiscal 2025 outlook to sales of $1.825 billion to $1.850 billion and Adjusted EBITDA of $400 million to $410 million, with current assumptions weighted toward the lower end. For shareholders, the large charge and weaker sales and Adjusted EBITDA are the key takeaways, and the results remain preliminary until the Form 10-Q is filed.
Q3 sales of $463 million, down 15 percent; Portfolio Optimization reduced sales by about $53 million, or 10 percent
Net loss of $742 million, or $(16.21) per diluted share, including the $706 million goodwill impairment charge
Adjusted EBITDA of $113 million, down 19 percent from $139 million a year earlier
Full-year fiscal 2025 outlook narrowed to sales of $1.825 billion to $1.850 billion and Adjusted EBITDA of $400 million to $410 million
Kontoor Brands named Joseph Alkire and Jennifer Broyles to expanded executive roles, with Alkire keeping the CFO title and adding global operations and Broyles becoming chief commercial officer. Chief Operating Officer Thomas Waldron is stepping down and will stay employed in a non-executive role through September 30, 2025, to help ensure an orderly transition.
Joseph Alkire remains Executive Vice President and Chief Financial Officer and adds Head of Global Operations, including supply chain
Jennifer Broyles becomes Executive Vice President, Chief Commercial Officer and Global Head of Brands, covering international and commercial operations for Lee and Wrangler
Thomas Waldron, Executive Vice President and Chief Operating Officer, is stepping down; his transition period ends September 30, 2025
The Helly Hansen business will continue to report to CEO Scott Baxter
O-I Glass reported a second-quarter 2025 net loss of $0.03 per diluted share, compared with earnings of $0.36 a year earlier, mostly due to $108 million in restructuring and asset impairment charges tied to halting the MAGMA program. Adjusted EPS rose to $0.53 from $0.44, and the company raised its full-year 2025 adjusted EPS guidance to $1.30 to $1.55 from $1.20 to $1.50.
Q2 2025 net loss attributable to the company of $0.03 per diluted share, versus $0.36 in Q2 2024; adjusted EPS $0.53 versus $0.44
Net sales of $1.7 billion, consistent with the prior year, with shipment volume down about 3 percent
Full-year 2025 adjusted EPS guidance raised to $1.30 to $1.55; free cash flow guidance unchanged at $150 to $200 million
Charges of approximately $45 million expected in Q3 2025 from the planned closure of one Americas plant and suspension of one furnace
Chemed reported second-quarter 2025 revenue up 3.8% to $618.8 million, but GAAP diluted earnings per share fell 23.2% to $3.57. The company cut its full-year 2025 EPS guidance to $22.00 to $22.30 from $24.95 to $25.45, citing a larger Medicare Cap billing limitation at VITAS, and said VITAS CEO Nicholas M. Westfall is resigning, with Joel L. Wherley to succeed him.
Q2 2025 revenue rose 3.8% to $618.8 million; GAAP diluted EPS was $3.57, down 23.2%, and adjusted diluted EPS was $4.27, down 21.9%.
Full-year 2025 EPS guidance revised to $22.00 to $22.30, versus the previously issued $24.95 to $25.45.
VITAS estimates a $19 million Florida Medicare Cap billing limitation for the cap year ending September 30, 2025, and accrued $16.4 million in Q2 2025.
Nicholas M. Westfall resigns as Chairman and CEO of VITAS effective July 29, 2025, and will remain an Executive Vice President through December 1, 2025; Joel L. Wherley will succeed him as VITAS CEO.
Regency Centers reported second-quarter 2025 results that improved from a year earlier, with Nareit FFO of $1.16 per diluted share versus $1.06 and net income of $0.56 per diluted share versus $0.54. The company raised its 2025 Nareit FFO guidance to $4.59 to $4.63 per diluted share from $4.52 to $4.58, which is a positive signal for shareholders.
Q2 2025 Nareit FFO was $212.1 million, or $1.16 per diluted share, up from $196.4 million, or $1.06, a year earlier
Same Property NOI, excluding lease termination fees, rose 7.4% for the quarter; 2025 guidance for this measure was raised to 4.5% to 5.0%
2025 Nareit FFO guidance raised to $4.59 to $4.63 per diluted share from $4.52 to $4.58
Subsequent to quarter end, on July 23, 2025, the company acquired five shopping centers in Orange County, CA, for $357 million
Essex Property Trust reported second-quarter 2025 Core FFO of $4.03 per diluted share, up 2.3% from $3.94 a year earlier and $0.07 above the midpoint of its guidance range. The company raised its full-year 2025 Core FFO guidance to $15.80 to $16.02 per diluted share, with a midpoint of $15.91, up $0.10. Reported net income per diluted share rose to $3.44 from $1.45, mainly due to a gain on sale of real estate that the company excludes from Core FFO.
Q2 2025 Core FFO per diluted share $4.03 vs. $3.94 in Q2 2024, up 2.3%
Q2 2025 net income per diluted share $3.44 vs. $1.45, driven primarily by a gain on sale of real estate
Full-year 2025 Core FFO per diluted share guidance raised to $15.80 to $16.02 from $15.56 to $16.06
Same-property revenue growth of 3.2% and NOI growth of 3.3% for Q2 2025 versus Q2 2024
American Assets Trust reported second-quarter 2025 results that showed lower per-share funds from operations (FFO) and net income than a year earlier, while the company raised the low end of its 2025 FFO guidance. The guidance change is modest, but the quarterly decline in core per-share earnings is the main point for shareholders to weigh.
Q2 2025 FFO per diluted share, excluding lease termination fees and litigation income, was $0.51, down from $0.60 in Q2 2024
Q2 2025 net income available to common stockholders was $5.5 million, or $0.09 per diluted share, versus $11.9 million in Q2 2024
2025 FFO per diluted share guidance raised to $1.89 to $2.01 from $1.87 to $2.01, a midpoint of $1.95, about 1% higher
Same-store cash net operating income fell 0.3% in Q2 2025 year over year, while six-month same-store cash NOI rose 1.4%
Zurn Elkay Water Solutions reported second-quarter 2025 net sales of $444.5 million, up 8% from $412.0 million a year earlier, and adjusted EPS of $0.42, up 27% from $0.33. The company raised its full-year 2025 adjusted EBITDA outlook to $420 million to $430 million from $405 million to $420 million, which points to a stronger expected year for shareholders.
Q2 net sales were $444.5 million, up 8% year over year; core sales also rose 8%.
GAAP diluted EPS from continuing operations was $0.29, up from $0.26; adjusted EPS was $0.42, up from $0.33.
Full-year 2025 adjusted EBITDA outlook raised to $420 million to $430 million from $405 million to $420 million.
The company repurchased 1.0 million shares for $33 million in the quarter and reported net debt leverage of 0.7x as of June 30, 2025.
Werner Enterprises reported second-quarter 2025 results, with total revenues of $753.1 million, down 1% from a year earlier. GAAP net income attributable to Werner rose 366% to $44.1 million, mainly because of a $45.7 million net liability reversal tied to a Texas Supreme Court ruling, while non-GAAP adjusted diluted EPS fell 36% to $0.11. The company also narrowed its 2025 net capital expenditure guidance to $145 million to $185 million.
Total revenues were $753.1 million, down $7.7 million or 1% year over year; Logistics revenue rose 6%, while Truckload Transportation Services revenue fell 4%.
GAAP diluted EPS was $0.72, up from $0.15; the company cited a $45.7 million net liability reversal from the Texas Supreme Court ruling as a non-GAAP adjustment.
Non-GAAP adjusted diluted EPS was $0.11, down 36% from $0.17, and adjusted operating margin was 2.2%, down 60 basis points.
2025 net capital expenditure guidance was lowered to $145 million to $185 million from $185 million to $235 million, and the TTS year-end truck count guidance was narrowed to 1% to 4% from 1% to 5%.
W. P. Carey reported second quarter 2025 revenues of $430.8 million, up 10.5% from a year earlier, and AFFO of $1.28 per diluted share, up 9.4%. The company raised its full-year 2025 AFFO guidance to $4.87 to $4.95 per diluted share, but net income attributable to the company fell 64.2% to $51.2 million, mainly due to a $69.0 million mark-to-market loss on its Lineage shares.
Q2 2025 revenues, including reimbursable costs, were $430.8 million, up 10.5% from $389.7 million in Q2 2024.
AFFO was $1.28 per diluted share, up from $1.17; net income attributable to W. P. Carey was $51.2 million, or $0.23 per diluted share, versus $142.9 million in Q2 2024.
2025 AFFO guidance was raised to $4.87 to $4.95 per diluted share, based on investment volume of $1.4 billion to $1.8 billion.
Quarterly dividend was increased to $0.900 per share, a 3.4% rise from the 2024 second quarter, and paid on July 15, 2025.
EXL reported second-quarter 2025 revenue of $514.5 million, up 14.7% from a year earlier, and raised its full-year 2025 revenue and adjusted diluted EPS guidance. The company also agreed on July 29, 2025 to pay Citibank $125 million under an accelerated share repurchase, part of its $500 million buyback program.
Q2 2025 revenue of $514.5 million, up 14.7%; diluted EPS of $0.40 versus $0.28, and adjusted diluted EPS of $0.49 versus $0.40
2025 revenue guidance raised to $2.050 billion to $2.070 billion from $2.035 billion to $2.065 billion
2025 adjusted diluted EPS guidance raised to $1.86 to $1.90 from $1.83 to $1.89
Adjusted operating income margin was 19.6%, down from 19.8% a year earlier; $125 million accelerated share repurchase with Citibank under the $500 million program
Nextracker reported first-quarter fiscal 2026 results for the period ended June 27, 2025, with revenue of $864 million, up 20% from a year earlier, and GAAP diluted EPS of $1.04 versus $0.84. The company raised its fiscal 2026 revenue and profitability ranges, including GAAP diluted EPS of $3.24 to $3.55, and disclosed three robotics and AI acquisitions, which matters to shareholders because it signals stronger growth and a higher profit outlook, while the company also cautions that U.S. policy changes could affect project timing and results.
Q1 FY26 revenue of $864 million, up 20% year over year, but down from $924 million in Q4 FY25
GAAP diluted EPS of $1.04 vs. $0.84 a year earlier; adjusted diluted EPS of $1.16 vs. $0.93
FY26 revenue outlook raised to $3.2 to $3.45 billion; GAAP diluted EPS range raised to $3.24 to $3.55
Three robotics and AI acquisitions made over the past four quarters with an aggregate investment of over $40 million, including contingent earnouts; $743 million cash and no debt at quarter end
MARA reported record second-quarter 2025 revenue of $238.5 million, up 64% from $145.1 million a year earlier, and net income of $808.2 million, or $1.84 per diluted share, compared with a net loss of $199.7 million in Q2 2024. The filing says the profit includes a $1.2 billion gain on the fair value of digital assets, so shareholders should note that much of the swing reflects the higher bitcoin price rather than operations alone. Adjusted EBITDA was $1.2 billion, compared with a loss of $125.5 million a year earlier.
Revenue was $238.5 million, up 64% from $145.1 million in Q2 2024; a 50% increase in the average bitcoin price contributed $76.6 million.
Net income was $808.2 million, or $1.84 per diluted share, versus a net loss of $199.7 million, or $0.72 per diluted share, in Q2 2024.
Purchased energy costs were $41.7 million versus $26.1 million, and G&A excluding stock-based compensation was $40.1 million versus $25.2 million.
On July 25, 2025, the company closed an upsized $950.0 million of 0.00% convertible senior notes due 2032 after quarter end.
InvenTrust Properties reported second-quarter 2025 net income of $95.9 million, or $1.23 per diluted share, up from $1.5 million, or $0.02, a year earlier, and Nareit FFO of $0.45 per diluted share, up from $0.44. The company raised its 2025 Same Property NOI growth guidance to 4.00% to 5.00% and its net income per diluted share guidance to $1.43 to $1.49, while keeping Nareit FFO and Core FFO guidance unchanged, and completed a $306.0 million sale of five California properties.
Q2 2025 net income was $95.9 million, or $1.23 per diluted share, including a $90.9 million gain on sale of investment properties, compared with $1.5 million, or $0.02, in Q2 2024.
Q2 2025 Nareit FFO was $0.45 per diluted share and Core FFO was $0.44, versus $0.44 and $0.43 a year earlier.
2025 guidance: Same Property NOI growth raised to 4.00% to 5.00% from 3.50% to 4.50%; net income per diluted share raised to $1.43 to $1.49 from $0.27 to $0.33.
Leased occupancy was 97.3% as of June 30, 2025, and the quarterly distribution of $0.2377 per share was paid on July 15, 2025.
Universal Health Services reported second-quarter 2025 net income attributable to UHS of $353.2 million, or $5.43 per diluted share, up from $4.26 a year earlier, on net revenues up 9.6% to $4.284 billion. The company raised its full-year 2025 Adjusted EPS-diluted forecast to $20.00 to $21.00 per share from $18.45 to $19.95, which matters to shareholders because it signals higher expected earnings for the year.
Q2 2025 diluted EPS was $5.43 versus $4.26 in Q2 2024; net revenues rose 9.6% to $4.284 billion
Results included approximately $101 million of incremental net Medicaid reimbursements, including about $58 million from the Tennessee Medicaid directed payment program
Revised 2025 Adjusted EPS-diluted forecast is $20.00 to $21.00 per share, up from the original $18.45 to $19.95
Q2 2025 included a pre-tax loss of approximately $25 million from a newly opened 142-bed hospital in Washington, D.C.
Graphic Packaging reported second quarter 2025 results on July 29, 2025. Net sales fell 1% to $2,204 million, and net income dropped to $104 million, or $0.34 per diluted share, from $190 million, or $0.62, a year earlier. The company also issued updated full-year 2025 guidance, which reflects first-half results and a narrower, modestly higher second-half sales outlook.
Second quarter Adjusted EBITDA was $336 million, versus $402 million a year earlier; Adjusted EBITDA margin was 15.3%, versus 18.0%.
Full-year 2025 guidance: net sales $8.4 billion to $8.6 billion, Adjusted EBITDA $1.45 billion to $1.55 billion, Adjusted EPS $1.90 to $2.20.
Net leverage ratio was 3.7x at June 30, 2025, versus 3.0x at December 31, 2024; 2025 capital spending is expected to be about $850 million.
During the second quarter, the company repurchased about 5.0 million shares for $111 million.
GATX reported second-quarter 2025 net income of $75.5 million, or $2.06 per diluted share, up from $44.4 million, or $1.21, a year earlier, and raised its full-year 2025 earnings guidance to $8.50 to $8.90 per diluted share. Total revenues rose to $430.5 million from $386.7 million, while Rail Europe fleet utilization fell to 93.3% from 95.8% a year earlier. For shareholders, the higher guidance reflects year-to-date results and expected stronger second-half performance at Engine Leasing.
Q2 2025 net income was $75.5 million, or $2.06 per diluted share, compared with $44.4 million, or $1.21, in Q2 2024.
Q2 2025 total revenues were $430.5 million, compared with $386.7 million in Q2 2024.
2025 full-year diluted EPS guidance was raised to $8.50 to $8.90, excluding tax benefits and other items and the pending Wells Fargo rail asset acquisition.
The Brookfield Infrastructure joint venture to acquire Wells Fargo's rail assets is expected to close in Q1 2026 or sooner, subject to regulatory approvals.
NexPoint Residential Trust reported a second-quarter 2025 net loss of $7.0 million, or $(0.28) per diluted share, compared with net income of $10.6 million a year earlier. The company cited a decrease in gains on sales of real estate of $18.7 million, and total revenues fell to $63.1 million from $64.2 million. The midpoint of its full-year 2025 loss per share guidance moved to $(1.31) from $(1.22), while the Core FFO per share guidance midpoint of $2.75 was affirmed, so shareholders face weaker GAAP results and a larger expected loss, although Core FFO and AFFO per share rose slightly.
Q2 2025 net loss of $7.0 million, or $(0.28) per diluted share, versus net income of $10.6 million, or $0.40, in Q2 2024
Total revenues of $63.1 million versus $64.2 million a year earlier; Q2 Same Store NOI decreased 1.1% to $38.0 million
Full-year 2025 loss per diluted share guidance midpoint revised to $(1.31) from $(1.22); Core FFO guidance midpoint of $2.75 affirmed
Q2 Core FFO of $0.71 per diluted share versus $0.69; the company repurchased 223,109 shares for $7.6 million
Norfolk Southern reported second-quarter 2025 revenue of $3.1 billion and diluted earnings per share of $3.41, up from $3.25 a year earlier, and narrowed its full-year revenue growth outlook to 2%-3%. The same day, it agreed to combine with Union Pacific in a stock and cash deal valued at an implied $320 per share, which would change what Norfolk Southern shareholders receive.
Under the agreement, Norfolk Southern shareholders receive 1.0 Union Pacific common share and $88.82 in cash per share; the implied total enterprise value is $85 billion, based on Union Pacific's July 16, 2025 closing price.
Q2 2025 net income was $768 million, up from $737 million; railway operating revenues were $3.1 billion, an increase of $66 million.
For 2025, the company expects revenue growth of 2%-3% and an adjusted operating ratio improvement of 100-150 basis points versus 2024, but says third-quarter 2025 is expected to be pressured.
Norfolk Southern will not hold a second-quarter 2025 earnings call because of the announcement; a joint investor call with Union Pacific is set for 8:30 AM ET on July 29, 2025.
Hubbell reported second-quarter 2025 net sales of $1,484.3 million, up 2% from a year earlier, and diluted EPS of $4.56 compared with $4.01. The company raised its full-year 2025 diluted EPS outlook to $16.25-$16.75 and its adjusted diluted EPS outlook to $17.65-$18.15. The company said a change to FIFO inventory accounting lowered cost of goods sold by $29 million in the quarter, or $0.42 per diluted share, which affects the reported results.
Second-quarter diluted EPS was $4.56 versus $4.01; adjusted diluted EPS was $4.93 versus $4.44
Second-quarter net sales were $1,484.3 million, up 2% (organic growth also 2%)
Operating margin was 22.7% versus 21.1% a year earlier
2025 diluted EPS outlook is $16.25-$16.75; adjusted diluted EPS outlook is $17.65-$18.15
Park National's board unanimously elected Matthew R. Miller, its current president, to succeed David L. Trautman as chief executive of Park and The Park National Bank, effective January 1, 2026. Trautman will remain Chair of both boards, and Miller, 47, has served as president and a director since May 2019. The filing describes a planned leadership transition with continuity in the board chair role.
Board elected Matthew R. Miller as CEO at a July 28, 2025 meeting, effective January 1, 2026.
David L. Trautman will continue as Chair of the Park and Park National Bank boards.
Miller's brother is a non-executive PNB employee who received less than $540,000 in total direct compensation for fiscal 2024.
Park issued a news release on July 29, 2025 announcing the succession (Exhibit 99.1).
Franklin Electric reported second quarter 2025 net sales of $587.4 million, up 8% from the prior year, and operating income of $88.1 million, up 11%. It kept its full-year 2025 guidance but said it expects a non-cash pension plan termination in the third quarter that will reduce EPS by approximately $1.00 per share, which is not included in that guidance.
Q2 net sales $587.4 million vs $543.3 million; operating income $88.1 million vs $79.1 million; operating margin 15.0%
Q2 diluted EPS $1.31 vs $1.26 in Q2 2024
Full-year 2025 guidance maintained: sales $2.09 billion to $2.15 billion; EPS $3.95 to $4.25
Third-quarter US Pension Plan termination expected to have a non-cash EPS impact of approximately $1.00 per share; operating cash flow for first six months was $32.0 million vs $35.0 million
Repligen reported second-quarter 2025 revenue of $182 million, up from $159 million a year earlier, and raised its full-year 2025 total reported revenue guidance to $715 million to $735 million. GAAP earnings per share rose to $0.26 from $0.10, while adjusted earnings per share fell to $0.37 from $0.40, a non-GAAP measure.
Q2 2025 revenue was $182 million, up 15% as reported and 17% organic non-COVID growth.
GAAP diluted EPS was $0.26 versus $0.10; adjusted diluted EPS was $0.37 versus $0.40.
Full-year 2025 total reported revenue guidance is $715 million to $735 million; GAAP net income guidance is $48 million to $51.5 million.
Cash, cash equivalents and short-term investments were $709 million at June 30, 2025, versus $757 million at December 31, 2024.
NeoGenomics reported second-quarter 2025 revenue of $181 million, up 10% from a year earlier, but its net loss widened to $45 million, including $20 million of impairment charges. The company also lowered its full-year 2025 revenue guidance to $720 million to $726 million from $747 million to $759 million, and widened its expected net loss, which matters to shareholders because it signals weaker results than previously expected.
Q2 2025 revenue rose 10% to $181 million; clinical revenue grew 16%, or 13% excluding Pathline
Q2 net loss increased 142% to $45 million, including $20 million of impairment charges; Adjusted EBITDA was $10.7 million, flat year over year
2025 revenue guidance lowered to $720 million-$726 million from $747 million-$759 million
2025 GAAP net loss guidance widened to $(116) million-$(108) million from $(85) million-$(77) million
CBRE reported second-quarter 2025 results on July 29, 2025, with revenue up 16% to $9.8 billion and GAAP net income up 65% to $215 million. The company raised its 2025 core EPS outlook to $6.10 to $6.20 from $5.80 to $6.10, which would be higher by at least $0.10 based on current forward currency rates.
Q2 2025 GAAP EPS rose 71% to $0.72 and core EPS rose 47% to $1.19.
Q2 revenue rose 16% to $9.8 billion; Q2 free cash flow was $2 million, down from $220 million a year earlier.
Stock repurchases since year-end 2024 totaled about 5.2 million shares for $663 million, with about $5.2 billion of authorization remaining as of June 30, 2025.
Incyte reported second-quarter 2025 total revenues of $1,216 million, up 16% from a year earlier, and GAAP net income of $405 million, compared with a loss of $444.6 million in the prior-year quarter. The company raised its full-year 2025 guidance for Jakafi and other oncology net product revenues, while absorbing a $242.3 million charge from its contract dispute settlement with Novartis.
Total revenues were $1,216 million in Q2 2025, up 16% year over year; Jakafi net product revenues were $764 million, up 8%.
GAAP diluted EPS was $2.04, compared with a loss of $2.04 per share in Q2 2024.
Full-year 2025 Jakafi net product revenue guidance was raised to $3,000-$3,050 million from $2,950-$3,000 million; other oncology guidance was raised to $500-$520 million from $415-$455 million.
The Novartis contract dispute settlement led to a $242.3 million difference recorded in contract dispute settlement expense; Incyte paid Novartis $280.0 million.
Neogen reported fiscal 2025 fourth-quarter revenue of $225.5 million, down 4.8% from a year earlier, and a net loss of $612.2 million, or $(2.82) per diluted share, driven mainly by a non-cash goodwill impairment tied to the former 3M Food Safety Division. Adjusted Net Income fell to $11.3 million, or $0.05 per diluted share, from $22.4 million, and the company initiated fiscal 2026 revenue guidance of $820 million to $840 million, which shareholders will weigh against the weaker current results.
Q4 revenue was $225.5 million, down 4.8% from $236.8 million; core revenue declined 2.9%.
Q4 net loss was $612.2 million, or $(2.82) per diluted share, versus a $5.4 million loss a year earlier.
Q4 Adjusted EBITDA was $40.6 million, an 18.0% margin, versus $53.0 million and 22.4% a year earlier.
Fiscal 2026 outlook: revenue of $820 million to $840 million and Adjusted EBITDA of $165 million to $175 million.
Duke Energy's subsidiary Piedmont Natural Gas agreed on July 27, 2025 to sell its Tennessee natural gas distribution business to Spire Inc. for $2.48 billion in cash, subject to adjustments. The company said net proceeds of $1.5 billion will help fund its $83 billion five-year capital plan, and it reaffirmed its 2025 adjusted EPS guidance.
Purchase price is $2.48 billion in cash, subject to adjustments for net working capital, regulatory assets and liabilities, and capital expenditures at closing.
About $800 million of proceeds will offset debt at Piedmont; net proceeds of $1.5 billion will fund Duke's $83 billion five-year capital plan.
Closing is expected in the first quarter of 2026, subject to Tennessee Public Utility Commission approval and the Hart-Scott-Rodino waiting period.
Duke reaffirmed its 2025 adjusted EPS guidance range of $6.17 to $6.42.
PayPal reported second-quarter 2025 results for the period ended June 30, 2025, with net revenues up 5% to $8.3 billion and non-GAAP earnings per diluted share up 18% to $1.40. The company raised its full-year 2025 non-GAAP EPS guidance to $5.15 to $5.30 from $4.95 to $5.10, which signals higher expected profit for shareholders.
Net revenues rose 5% to $8.3 billion; GAAP EPS rose 20% to $1.29 and non-GAAP EPS rose 18% to $1.40.
Full-year 2025 non-GAAP EPS guidance raised to $5.15 to $5.30, up from $4.95 to $5.10; GAAP EPS guidance raised to $4.90 to $5.05 from $4.80 to $4.95.
Returned $1.5 billion to stockholders through repurchases of about 22 million shares in the quarter; operating cash flow was $898 million, down 41%.
JetBlue reported a second-quarter 2025 GAAP net loss of $74 million, or $(0.21) per share, compared with net income of $25 million, or $0.07 per share, a year earlier. Operating revenue fell 3.0% to $2.4 billion, and the company raised its expected JetForward EBIT benefit range to $850 to $950 million by the end of 2027, while also re-instating its initial full-year unit cost guidance.
Q2 2025 GAAP net loss of $74 million, or $(0.21) per share, versus net income of $25 million, or $0.07 per share, in Q2 2024
Operating revenue of $2.4 billion, down 3.0% year over year; operating margin of 0.3% versus 2.3% a year earlier
Non-GAAP adjusted net loss of $58 million, or $(0.16) per share, excluding special items and investment gains and losses
Average aircraft on the ground now expected to be fewer than 10 this year, down from mid-to-high teens; full-year 2025 CASM ex-fuel guidance of 5.0% to 7.0% increase
Johnson Controls reported fiscal third-quarter 2025 sales of $6.1 billion, up 3% from a year earlier and up 6% organically, and raised its full-year fiscal 2025 adjusted EPS guidance to $3.65 to $3.68 from about $3.60. GAAP earnings per share from continuing operations fell to $0.94 from $1.27, so shareholders see stronger sales and guidance alongside lower reported profit.
Q3 sales of $6.1 billion rose 3% as reported and 6% organically versus the prior-year quarter.
GAAP EPS from continuing operations was $0.94 versus $1.27 a year earlier; adjusted EPS was $1.05.
Full-year fiscal 2025 adjusted EPS guidance raised to $3.65 to $3.68, previously about $3.60.
Fiscal Q4 adjusted EPS guidance set at $1.14 to $1.17.
Baker Hughes agreed to buy Chart Industries in an all-cash deal valued at $13.6 billion in enterprise value, with Chart shareholders receiving $210 per share. Baker Hughes has a $14.9 billion bridge loan commitment to fund the deal, and the companies expect to complete it by mid-year 2026, subject to Chart shareholder and regulatory approvals.
Chart shareholders will receive $210 per share in cash; enterprise value is $13.6 billion
Baker Hughes has a bridge loan commitment of up to $14.9 billion, expected to be replaced with permanent debt financing before close
Baker Hughes projects net leverage of 2.25x at close, de-leveraging to 1.0-1.5x within 24 months after close
Chart would pay Baker Hughes a $250 million termination fee under specified circumstances; Baker Hughes would pay $500 million in certain regulatory or legal failure cases
Royal Caribbean reported second-quarter 2025 diluted EPS of $4.41, up from $3.11 a year earlier, and total revenues of $4.5 billion, up from $4.1 billion. The company raised its full-year 2025 Adjusted EPS guidance to $15.41 to $15.55, which it said reflects stronger second-quarter performance and lower expected spending.
Q2 2025 diluted EPS was $4.41 vs. $3.11 in Q2 2024; Adjusted EPS was $4.38 vs. $3.21.
Total revenues were $4.5 billion for the quarter, vs. $4.1 billion a year earlier.
Full-year 2025 Adjusted EPS guidance is $15.41 to $15.55, which the company says is approximately 31% growth year over year.
Third-quarter 2025 Adjusted EPS is guided to $5.55 to $5.65.
Flowserve reported second-quarter 2025 sales of $1.19 billion, up 2.7% from a year earlier, with reported EPS of $0.62 and adjusted EPS of $0.91, up 24.7%. The company raised its full-year 2025 adjusted EPS guidance to $3.25 to $3.40 from $3.10 to $3.30, while bookings fell 13.8% and it ended its merger agreement with Chart Industries, receiving a $266 million termination payment.
Q2 sales of $1.19 billion, up 2.7% from $1.16 billion; bookings of $1.07 billion, down 13.8%
Reported EPS of $0.62 vs. $0.55 a year earlier; adjusted EPS of $0.91 vs. $0.73
Full-year 2025 adjusted EPS guidance raised to $3.25 to $3.40 from $3.10 to $3.30
Flowserve will receive a $266 million termination payment after ending its merger agreement with Chart Industries
Armstrong World Industries reported second-quarter 2025 net sales of $424.6 million, up 16.3%, and diluted EPS of $2.01, up 34%. The company raised its full-year 2025 guidance for net sales, adjusted EBITDA, adjusted diluted EPS and adjusted free cash flow, citing strong results in the first half.
Q2 operating income rose 29.7% to $123.2 million; operating margin was 29.0%, up 300 basis points.
Full-year 2025 adjusted diluted EPS guidance raised to $7.15 to $7.30, from a 2024 actual of $6.31.
Full-year 2025 net sales guidance raised to $1.600 billion to $1.630 billion, versus $1.446 billion in 2024.
Company repurchased shares for $30 million in Q2 and had $610 million remaining under its buyback authorization as of June 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.